Beginning July 31, 2026, a U.S. pharmaceutical tariff will apply to patented products and their APIs, beginning with large companies. Beroe Inc.'s Mathini Ilancheran breaks down the tariff's impact, explores its risks, and proposes five procurement strategies to addressing them.
- Where Trial Budgets And Supply Plans Go Off Track — Earlier Than You Think
- From Policy To Practice: Embedding Export Compliance In Clinical Supply
- What CAPAs Don't Catch: 3 Hidden ATMP Cold Chain Vulnerabilities By Design
- AI And Digital Tools Advance Clinical Trial Supply Chains
- Solving Pharmacy And Clinical Supply Challenges In Decentralized Trials
- How The Strait Of Hormuz Crisis Is Stalling U.S. Medical Breakthroughs
- The Hidden Bottleneck: Clinical Supply Strategy In Study Start-Up
- Why More Tools Won't Fix Clinical Supply
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Web-Based CDR System: Precision Without Compromise
Validated research confirms that web-based cognitive testing maintains the millisecond precision of traditional hardware, ensuring high-quality data for decentralized clinical trials.
-
Rare Diseases And The Integrated CDMO Support System
Champion the rare‑disease community by advancing development models built on precision, continuity and global coordination that ensure every dose reaches the patients who need it most.
-
How A Biotech Startup Transformed Their Clinical Trial Supply Management
Don’t let your trial get lost in the shuffle of legacy vendors. See how a high-touch, consultative approach can protect your study’s future.
-
FastChain®: A Solution For Made-To-Order Gene Replacement Therapy Study
Adopt a demand-led clinical supply strategy to reduce waste, optimize limited product supply, and accelerate patient access across global clinical trials.
-
How Regional Logistics Strategy Supports Clinical Success In Europe
In an era where trial delays, customs bottlenecks, and fragmented regulations can derail even the most promising program, logistics has become a strategic asset.
-
Risk Mitigation Planning For Pharmaceutical Tariffs
Examine the potential ramifications of proposed tariffs on the pharmaceutical and biotechnology sectors, highlighting critical concerns regarding national security and supply chain stability.
-
Industry Trends: Clinical Logistics Outsourcing
Understanding industry trends, market dynamics, and the selection criteria decision-makers apply when choosing a clinical logistics service provider informs and contextualizes outsourcing decisions.
-
Specializing In Small And Early-Stage Partners, Not Just Small Batches
Many small and/or early-stage companies are not aware of the need, or the possibility, of finding a CDMO that specializes in meeting their specific requirements.
-
Transforming Clinical Supply Planning From Spreadsheets To Smart Forecasting
Streamline your clinical supply forecasting and reduce risk by moving beyond manual spreadsheets to an integrated, real-time supply management solution.
-
Outsourcing Your Highly Potent Oncology Drug Product
Precision oncology treatments require specialized manufacturing and packaging, leading companies to outsource production. Assessing a CDMO’s highly potent processing capabilities is critical.
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.